Viewing data from:

OTICAIR

ANDA

HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE | A064065 | BAUSCH AND LOMB INC

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: CASPORYN HC(TE code: AT)

Products (1)

#001 — 1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML

0 patents0 exclusivities▴

SUSPENSION/DROPS;OTIC | Approved: Aug 28, 1996

No patent or exclusivity listings for this strength.

Change History (2)

Recent changes detected for this application.

MODIFIEDApplicant7/1/2026

Bausch and Lomb's applicant name for OTICAIR (hydrocortisone; neomycin sulfate; polymyxin B sulfate) was updated from "Bausch and Lomb" to "Bausch and Lomb Inc" in FDA records.

Old: BAUSCH AND LOMB

New: BAUSCH AND LOMB INC

MODIFIEDApplicant Full Name7/1/2026

Bausch and Lomb Pharmaceuticals Inc. updated its corporate name to Bausch and Lomb Inc. for OTICAIR (hydrocortisone, neomycin sulfate, polymyxin B sulfate) NDA 064065.

Old: BAUSCH AND LOMB PHARMACEUTICALS INC

New: BAUSCH AND LOMB INC